384 related articles for article (PubMed ID: 32205481)
41. Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.
Kishikawa S; Hayashi T; Shimizu J; Fuwa B; Nonomura A; Saito T; Yatabe Y; Yao T
Virchows Arch; 2022 Nov; 481(5):793-797. PubMed ID: 35670854
[TBL] [Abstract][Full Text] [Related]
42. Cytopathological features of secretory carcinoma of salivary glands and ancillary techniques in its diagnostics: impact of new Milan system for reporting salivary gland cytopathology.
Miesbauerová M; Tommola S; Šteiner P; Baněčková M; Skálová A; Kholová I
APMIS; 2019 Jul; 127(7):491-502. PubMed ID: 30942913
[TBL] [Abstract][Full Text] [Related]
43. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.
Hamamoto Y; Harada H; Kohara M; Honma K; Nakatsuka SI; Morii E
Med Mol Morphol; 2021 Mar; 54(1):23-30. PubMed ID: 32488412
[TBL] [Abstract][Full Text] [Related]
45. A rare malignancy of the parotid gland in a 13-year-old Taiwanese boy: case report of a mammary analogue secretory carcinoma of the salivary gland with molecular study.
Hwang MJ; Wu PR; Chen CM; Chen CY; Chen CJ
Med Mol Morphol; 2014 Mar; 47(1):57-61. PubMed ID: 23955668
[TBL] [Abstract][Full Text] [Related]
46. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
[TBL] [Abstract][Full Text] [Related]
47. Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report.
Wagner F; Greim R; Krebs K; Luebben F; Dimmler A
Diagn Pathol; 2021 Aug; 16(1):73. PubMed ID: 34372873
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic Approaches for Salivary Gland Tumors with Secretory and Microcystic Features.
Woo HY; Choi EC; Yoon SO
Head Neck Pathol; 2018 Jun; 12(2):237-243. PubMed ID: 29139086
[TBL] [Abstract][Full Text] [Related]
50. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
[TBL] [Abstract][Full Text] [Related]
51. Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.
Dogan S; Wang L; Ptashkin RN; Dawson RR; Shah JP; Sherman EJ; Michael Tuttle R; Fagin JA; Klimstra DS; Katabi N; Ghossein RA
Mod Pathol; 2016 Sep; 29(9):985-95. PubMed ID: 27282352
[TBL] [Abstract][Full Text] [Related]
52. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
[TBL] [Abstract][Full Text] [Related]
53. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
55. ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
Agaimy A; Baněčková M; Ihrler S; Mueller SK; Franchi A; Hartmann A; Stoehr R; Skálová A
Am J Surg Pathol; 2021 Sep; 45(9):1166-1178. PubMed ID: 33871952
[TBL] [Abstract][Full Text] [Related]
56. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
[TBL] [Abstract][Full Text] [Related]
57. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
[TBL] [Abstract][Full Text] [Related]
58. Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors.
Kurihara T; Suehara Y; Akaike K; Hayashi T; Kohsaka S; Ueno T; Hasegawa N; Takagi T; Sasa K; Okubo T; Kim Y; Mano H; Yao T; Kaneko K; Saito T
Sci Rep; 2020 Oct; 10(1):18724. PubMed ID: 33127954
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland: Two case reports.
Ogawa M; Yokoo S; Yamaguchi T; Suzuki K; Seki-Soda M; Shimizu T; Kurihara J; Makiguchi T
Medicine (Baltimore); 2021 Dec; 100(51):e28390. PubMed ID: 34941172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
